Otrivine Menthol Abschwellend (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otrivine Menthol Abschwellend, is a nasal decongestant presented as a nasal spray for topical intranasal use. It provides temporary relief of nasal congestion caused by colds, sinusitis, allergic rhinitis and other upper‑respiratory conditions.

GNH USA supplies Otrivine Menthol Abschwellend as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline acts on the nasal mucosa to reduce swelling and improve airflow, making it useful for several common ENT conditions.

- Common cold: alleviates nasal blockage and improves breathing. - Allergic rhinitis: reduces congestion associated with seasonal or perennial allergies. - Acute sinusitis: eases nasal obstruction during early stages. - Post‑operative nasal care: helps maintain airway patency after nasal surgery.

Adverse reactions are generally mild and related to the local action of the spray.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing shortly after application. - Headache. - Altered taste or bitter taste. - Mild epistaxis.

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) after prolonged use. - Severe hypertension or hypertensive crisis. - Cardiac arrhythmias. - Allergic reactions such as rash, itching, or swelling. - Nasal ulceration or perforation. - Severe epistaxis requiring medical attention.

Use of Xylometazoline requires attention to duration, patient conditions, and proper storage.

- Use duration: limit to 3‑5 days to avoid rebound congestion. - Pre‑existing hypertension: monitor blood pressure as vasoconstriction may elevate levels. - Cardiovascular disease: caution in patients with arrhythmias or coronary disease. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Children under 6 years: not recommended unless advised by a physician. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Xylometazoline may interact with systemic medications that affect blood pressure or cause additive nasal effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Oral antihypertensive agents: possible additive blood pressure changes.

Moderate Interactions (Monitor Closely): - Other nasal decongestants: increased risk of vasoconstriction and rebound congestion. - Beta‑blockers: may mask tachycardia symptoms. - Alcohol: can enhance dizziness or light‑headedness. - Tricyclic antidepressants: potential for additive cardiovascular effects.